Morgans reduced their price target to $1.67 from $1.83 on the back of the vaccine news from Pfizer. That IMO is a very premature decision as the next 12-18 months quality retailers should do very well. A massive overreaction on the Retail sector when profits are still very healthy with record dividends here at AX1 treat analysts like horse racing commentators most of the time they have NFI
Ann: FY20 Full Year Results Presentation, page-133
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AX1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.22 |
Change
0.060(2.78%) |
Mkt cap ! $1.249B | |||
| Open | High | Low | Value | Volume |
| $2.18 | $2.22 | $2.16 | $7.621M | 3.464M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 44286 | $2.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.22 | 34073 | 6 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| AX1 (ASX) Chart |